Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Leopard Biosciences ApS
APS
In liquidation
Advertising protection
CVR 44202603
Ole Maaløes Vej 3, 2200
København N
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2023 · 2 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Leopard Biosciences ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2024
Income statement
DKK thousands
Item
2024
Gross profit
-100
Staff expenses
-171
EBITDA
-271
Depreciation & amort.
-511
EBIT
-781
Net financials
-196
Profit before tax
-977
Tax
-0
Net profit
-977
Balance sheet
DKK thousands
Item
2024
Total assets
3.760
Equity
-937
Long-term debt
4.266
Short-term debt
431
Total debt
4.697
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-27058000.0%
This company
2024
2024
Equity ratio
-24.9%
This company
38.2%
Market median
-165% vs market
2024
2024
Return on equity
-97710600.0%
This company
18.4%
Market median
-531035970% vs market
2024
2024
Net profit margin (of gross profit)
-97710600.0%
This company
2024
2024
Asset turnover (of gross profit)
-0.03×
This company
2024
2024
Debt / equity
5.01×
This company
0.62×
Market median
-708% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2023-07-25 – 2024-12-31
View
PDF
More on Leopard Biosciences ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
